Tregs have a potential role in the progression of OS, and the impetus of the antitumor efficacy of anti-PD-1 antibodies in OS mouse models may be decreased numbers of FOXP3+Tregs and increased tumor-infiltrating lymphocytes in the tumor microenvironment (36). The gene discussed is FOXP3; the disease is neoplasm.